NCT06709131

A Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Study Summary

A Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Want to learn more about this trial?

Request More Info

Interventions

CAR-T cells( chimeric antigen receptor T cells)DRUG
CAR-T cells( chimeric antigen receptor T cells)

Study Locations

FacilityCityStateCountry
The first affiliated hospital of medical college of zhejiang universityHangzhouZhejiangChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026